- David Klatzmann, MD. (Pierre & Marie Curie Univ., France)
- Yasufumi Kaneda, MD., PhD (Osaka Univ., Japan)
- Nagy Habib, PhD. (Livercyte Limited., Imperial College London, UK)
- Michael Yu, PhD. (Innovent Biologics Inc., China)
- Kam M Hui, MD., PhD. (National Cancer Centre, Singapore)
- Jin Su Kim, PhD. (ToolGen Inc., Seoul National Univ., Korea)
- Keon Wook Kang, MD., PhD. (Seoul National Univ., Korea)
- Masatoshi Tagawa, MD., PhD (Chiba Cancer Centre Research Institute, Japan)
- Mark Tangney, PhD. (Cork Cancer Research Centre, Ireland)
- Toh Han Chong, PhD. (National Cancer Center, Singapore)
- Farzin Farzaneh, PhD. (King’s Collage London, UK)
- Min Liang, PhD. (TOT Inc, China)
- Leonard W. Seymour, PhD. (Oxford Univ., UK)
- Hiromi Kumon, MD., PhD. (Okayama Univ., Japan)
- Albert Deisseroth, MD., PhD. (US FDA, USA)
- Manfred Dietel, MD., PhD. (University Hospital Charite, Germany)
- Won Jong Kim, Ph.D (POSTECH, Korea)
- Noriyuki Kasahara, MD., PhD. (Univ. of Miami, USA)
- Kah Whye Peng, Ph.D. (Department of Molecular Medicine, Mayo Clinic)
- Arum Yoon, Ph.D. (Department of Bioengineering College of Engineering Hansang Univ.)
|